Objective:

To explore the relationship between the dopamine-melatonin axis and myopia progression, and how restoring this axis may enhance the effectiveness of current myopia treatments.

Key Findings:

• Restoring the dopamine-melatonin axis may enhance the effectiveness of existing myopia treatments by improving the biological environment.
• Dopamine acts as a stop signal for axial elongation during the day, while melatonin provides protective effects at night.
• Disruptions in sleep and light exposure can accelerate myopia progression, particularly in children, highlighting the need for behavioral interventions.

Interpretation:

The findings suggest that behavioral modifications targeting the dopamine-melatonin axis could serve as effective adjuncts to traditional myopia treatments, potentially altering the biological environment that contributes to myopia development.

Limitations:

• The article does not provide empirical data directly linking behavioral changes to myopia outcomes.
• Further research is needed to establish causative relationships and the long-term effects of restoring the dopamine-melatonin axis.
• Individual responses to behavioral changes may vary, necessitating personalized approaches.

Conclusion:

Restoring the dopamine-melatonin axis represents a promising evolution in myopia management, shifting the focus from merely reacting to myopia progression to actively shaping the biological factors that influence it.